Literature DB >> 33196494

Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.

Hanne M L Zimmermann1, Vita W Jongen1, Anders Boyd1,2, Elske Hoornenborg3, Maria Prins1,4, Henry J C de Vries3,5, Maarten F Schim van der Loeff1,4, Udi Davidovich1,6.   

Abstract

OBJECTIVE: To explore the frequency of and reasons for using condoms among men who have sex with men (MSM) on preexposure prophylaxis (PrEP).
DESIGN: We analyzed quantitative app-based diary data on daily sexual practices (August 2015-February 2019) and qualitative in-depth interviews among MSM using daily PrEP and event-driven PrEP (edPrEP) in the Amsterdam PrEP demonstration project.
METHODS: Participants could report daily about sex acts, PrEP use and condom use per partner type (steady and casual partners). We examined four strategies of PrEP and condom use: PrEP only, PrEP and condoms, condoms only, and neither strategy. We compared the proportions of sex acts per strategy between PrEP regimens. In 43 in-depth interviews, we explored motives for implementing each strategy.
RESULTS: Three hundred and fifty-two participants reported 48 949 anal sex acts. PrEP only was the most common strategy employed with any partner type (81%, n = 39 650/48 949) and was motivated by anticipating more pleasurable sex, sexually transmitted infection's perceived curability, and habituation to condomless sex. Combining PrEP and condoms was more often chosen for sex acts with casual partners (18%, n = 6829/37 317) than with steady partners (5%, n = 614/11 632) and was linked to, for example, higher perceived vulnerability for sexually transmitted infections or HIV and avoidance of PrEP disclosure. Condoms only was uncommon but occurred particularly among edPrEP users (4%, n = 379/8695). Applying neither strategy was common among edPrEP users with steady partners (25%, n = 538/2122) and was motivated by low perceived HIV risk.
CONCLUSION: Condoms remain a viable option for PrEP users in certain settings. Condoms were applied in higher risk settings, to avoid PrEP disclosure, or as substitute for PrEP, especially among edPrEP users.

Entities:  

Mesh:

Year:  2020        PMID: 33196494     DOI: 10.1097/QAD.0000000000002714

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Switching to Non-daily Pre-exposure Prophylaxis Among Gay and Bisexual Men in Australia: Implications for Improving Knowledge, Safety, and Uptake.

Authors:  Steven P Philpot; Dean Murphy; Curtis Chan; Bridget Haire; Doug Fraser; Andrew E Grulich; Benjamin R Bavinton
Journal:  Sex Res Social Policy       Date:  2022-06-17

2.  Preference for daily versus on-demand pre-exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real-world Oral PrEP Demonstration study.

Authors:  Jing Zhang; Jun-Jie Xu; Hong-Yi Wang; Xiao-Jie Huang; Yao-Kai Chen; Hui Wang; Zhen-Xing Chu; Qing-Hai Hu; Xiao-Qing He; Yao Li; Lu-Kun Zhang; Zhi-Li Hu; Ran-Tong Bao; Shang-Cao Li; Hang Li; Hai-Bo Ding; Yong-Jun Jiang; Wen-Qing Geng; Sean Sylvia; Hong Shang
Journal:  J Int AIDS Soc       Date:  2021-02       Impact factor: 5.396

3.  A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.

Authors:  Janan Janine Dietrich; Nadia Ahmed; Emily L Webb; Gugulethu Tshabalala; Stefanie Hornschuh; Mamakiri Mulaudzi; Millicent Atujuna; Lynda Stranix-Chibanda; Teacler Nematadzira; Andrew Sentoogo Ssemata; Richard Muhumuza; Janet Seeley; Linda-Gail Bekker; Helen A Weiss; Neil Martinson; Julie Fox
Journal:  J Int AIDS Soc       Date:  2022-08       Impact factor: 6.707

4.  Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men.

Authors:  Vita W Jongen; Hanne M L Zimmermann; Anders Boyd; Elske Hoornenborg; Mark A M van den Elshout; Udi Davidovich; Yvonne T H P van Duijnhoven; Henry J C de Vries; Maria Prins; Maarten F Schim van der Loeff; Liza Coyer
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-15       Impact factor: 3.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.